HeCaToS Hepatic and Cardiac Toxicity Systems modelling
HeCaToS aims at developing integrative in silico tools for predicting human liver and heart toxicity. The objective is to develop an integrated modeling framework, by combining advances in computational chemistry and systems toxicology, for modelling toxic perturbations in liver and heart across multiple scales. This framework will include vertical integrations of representations from drug(metabolite)-target interactions, through macromolecules/proteins, to (sub-)cellular functionalities and organ physiologies, and even the human whole-body level. In view of the importance of mitochondrial deregulations and of immunological dysfunctions associated with hepatic and cardiac drug-induced injuries, focus will be on these particular Adverse Outcome Pathways. Models will be populated with data from innovative in vitro 3D liver and heart assays challenged with prototypical hepato- or cardiotoxicants; data will be generated by advanced molecular and functional analytical techniques retrieving information on key (sub-)cellular toxic evens. For validating perturbed AOPs in vitro in appropriate human investigations, case studies on patients with liver injuries or cardiomyopathies due to adverse drug effects, will be developed, and biopsies will be subjected to similar analyses. Existing ChEMBL and diXa data infrastructures will be advanced for data gathering, storing and integrated statistical analysis.
Model performance in toxicity prediction will be assessed by comparing in silico predictions with experimental results across a multitude of read-out parameters, which in turn will suggest additional experiments for further validating predictions. HeCaToS, organized as a private-public partnership, will generate major socioeconomic impact because it will develop better chemical safety tests leading to safer drugs, but also industrial chemicals, and cosmetics, thereby improving patient and consumer health, and sustaining EU’s industrial competitiveness.
Prof Jos CS Kleinjans PhD
Prof. Kleinjans studied biology at the Catholic University of Nijmegen and took a training in general biology and further trainings in physiological p more ...
Yannick JM Schrooders MSc
Tom RW Linssen BSc
Tom Linssen was born on December 14th 1990 in Nijmegen, the Netherlands. In 2011 he started his Bachelor in Bioinformatics at the University of Applie more ...
René JHM Reijnders Drs
Rene Reijnders graduated in Health Sciences in 1992 at the Maastricht University (The Netherlands). After that he joined the Department of Epidemiolog more ...
Danyel GJ Jennen PhD
Dr. Danyel Jennen is Associate Professor in the field of toxicoinformatics at the UM Department of Toxicogenomics and he heads its core unit on toxico more ...
Jacco J Briedé PhD
Dr. Ing. Jacco Briedé first took an education as a technician, with a (bio)chemical specialization, at the technical school in Utrecht. During his tra more ...
Florian Caiment PhD
Dr. Florian Caiment was born on the 15th of August 1980 in Troyes, France. After studying general biology in Reims then Nancy universities (France), h more ...
Twan van den Beucken PhD
Dr. Twan van den Beucken studied technical microbiology at Fontys University of Applied Sciences in Venlo, were he graduated cum laude in 1998. In the more ...
Rob AJ Schlooz BSc
Rob Schlooz graduated in Business Economics in 2001 at the Hogeschool Zuyd. He has worked for a year at the administrative department of a hotel in Ma more ...
Juan Ochoteco MSc
Juan Ochoteco Asensio was born on March 29th, 1994 in Barcelona, Spain. In 2012, he started his Bachelor in Biochemistry at the Faculty of Sciences of more ...
Nhan Nguyen MSc
Nhan Nguyen was born on December 14th in Hanoi, Vietnam. She studied general biology at Vietnam National University in Hanoi, where she graduate more ...
Marcha CT Verheijen MSc
Marcha Verheijen was born on March 25th 1987 in Amersfoort, the Netherlands. At Leeuwenborgh Sittard, she studied ‘Chemical Laboratory Techniques’ fro more ...